Introduction
============

Independently recurring mutations (homoplasy) in human mitochondrial DNA (mtDNA) phylogeny is a well-known phenomenon, and is thought to be the consequence of the high mtDNA mutation rate ([@evt058-B41]). As most mutational events are removed by negative selection, only a subset of the recurrent mutations will be retained in the population, of which the majority would have little or no effect and hence can be considered as neutral. Is it possible that homoplasic mtDNA mutations that were retained and inherited in the mtDNA phylogeny possess adaptive properties and were thus positively selected?

Although population fixation of mtDNA variants has traditionally been attributed to genetic drift, it has been repeatedly shown that certain common human mtDNA genetic variants possess functional attributes and are, therefore, likely to be under selective constraints ([@evt058-B63]). As natural selection acts on phenotype, one would expect that such mtDNA variation would affect mitochondrial function. Indeed, cell culture experiments demonstrated that human mtDNA polymorphisms affected mitochondrial activities, such as calcium uptake ([@evt058-B24]), reactive oxidation species (ROS) production ([@evt058-B37]), and mtDNA transcription ([@evt058-B54]). Genetic association studies revealed the phenotypic impact of human mtDNA genetic backgrounds, especially on age-related phenotypes, such as type 2 diabetes mellitus and Parkinson's disease (reviewed by [@evt058-B35]). Moreover, certain mtDNA variants were shown to possess adaptive attributes in multiple metazoan taxa ([@evt058-B7]). Finally, co-evolution among mtDNA- and nuclear DNA-encoded factors underlined the functional importance of mtDNA variants for protein--protein interactions ([@evt058-B16], [@evt058-B15]; [@evt058-B1]). Although the functional importance and phenotypic effects of common mtDNA variants is clear, functionality of recurrent mutations found in the stems of unrelated mtDNA phylogenetic nodes, that is, recurrent nodal mutations (RNMs), is less obvious.

Recently, it was suggested that recurring mutations in human mtDNA tend to affect positions of lesser functional importance ([@evt058-B41]). However, several pieces of evidence indicate that a subset of recurring mtDNA mutations are potentially functional and may even offer adaptive value. First, mtDNA mutations that became recurrently fixed in several independent cancer samples recapitulated ancient mtDNA genetic backgrounds (haplogroups), thus suggesting commonalities in the selective constraints acting on the mitochondrial genome in cancer and during human evolution ([@evt058-B69]). Second, mtDNA haplogroups T and N1b2 share an amino acid replacement (mutation A4917G) that altered a highly evolutionary conserved position, thus affecting susceptibility to reduced sperm motility ([@evt058-B46]) and to complications in type 2 diabetes patients ([@evt058-B14]). Finally, the mutation at position 1,555 that causes hearing loss in humans exposed to aminoglycosides recurred in orangutan mtDNA and affected mitochondrial function in cell culture ([@evt058-B40]). Although promising, these pieces of evidence do not reveal the extent of this phenomenon, that is, how many of the total set of mtDNA RNMs carry functional attributes.

Here, we tested the hypothesis that a subset of the single nodal mutation (SNMs) and RNMs in the human mtDNA phylogeny carries functional properties and has survived years of evolution due to its adaptive nature. To test our hypothesis, we constructed a detailed phylogenetic tree from 9,868 publicly available, nonredundant, whole human mtDNA sequences (and out-group sequences) that was in complete agreement with the most updated mtDNA phylogenetic tree topology ([@evt058-B2]). Then, we identified all of the mutational events that occurred during human mtDNA phylogeny and associate them with each of the obtained tree branches and lineages. By bioinformatics assessment of the functional potential of nodal synonymous, nonsynonymous, and RNA genes mutations, we identified the most likely candidate SNMs and RNMs to have been retained in the human population due to positive selection.

Materials and Methods
=====================

Whole mtDNA Sequences
---------------------

We retrieved 9,862 publicly available (Genbank) whole human mtDNA sequences, excluding redundancies ([supplementary table S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online), that were used to construct the mtDNA phylogenetic tree ([@evt058-B62]; [@evt058-B2]). We retrieved the NCBI accession numbers of these sequences and their phylogenetic assignment from the mtDNA Community website ([www.mtdnacommunity.org](www.mtdnacommunity.org), last accessed April 22, 2013), whereas the sequences were downloaded from the PhyloTree site ([www.phylotree.org](www.phylotree.org), last accessed April 22, 2013). The 9,862 sequences, together with six Neanderthal sequences (*Homo sapiens* neanderthalensis accession numbers: NC_011137.1, FM865409.1, FM865407.1, FM865408.1, FM865410.1, and FM865411.1) that were isolated from archaeological specimens ([@evt058-B3]), were aligned using MAFFT (mafft.cbrc.jp/alignment/server/). MAFFT was used because it is specifically designed to analyze multiple sequence alignments comprising thousands of sequences.

Phylogenetic Analysis
---------------------

The phylogenetic tree of whole mtDNA sequences was constructed in several stages. First, we used the lineage/cluster nomenclature published in the tree generated by [@evt058-B2] ([supplementary table S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online). To predict ancestral sequences for each cluster, we used the Phylip software package ([www.phylip.com](www.phylip.com), last accessed April 22, 2013), especially utilizing the maximum likelihood method with the molecular clock option. Briefly, trees were generated for each cluster of sequences and the ancestral sequences were predicted from the best tree out of 500 Jumble repetitions (i.e., randomized input order of sequences, as outlined in the manual of the Phylip software, [www.phylip.com](www.phylip.com), last accessed April 22, 2013). Second, the resulting sequence list, which included an ancestral sequence from each cluster (i.e., the predicted ancestral sequences of each of the subtrees), was used to generate an ancestral phylogenetic tree ([supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online). This phylogenetic tree was constructed by MEGA5 ([@evt058-B56]), using the neighbor-joining method ([@evt058-B48]) with the following parameters: gaps/missing data treatment -- pairwise deletion, bootstrap -- 1000X; substitution model: maximum composite likelihood method. Similar tree topology was received using fastTree ([@evt058-B42]) and PhyML ([@evt058-B20]). For the sake of simplicity, we present only the NJ tree, which is consistent with previously published human mtDNA tree topology ([@evt058-B62]; [@evt058-B2]). We used DNA parsimony (Phylip software package) to analyze the ancestral phylogenetic tree ([supplementary fig. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online) containing 563 ancestral sequences. We developed a bioinformatics tool to integrate data from the DNA Parsimony Algorithm program with the phylogenetic analysis (i.e., the 563 sub-trees, corresponding to the ancestral sequences created by the ML method by the molecular clock option). This enabled a global view of all mutational events that occurred in human mtDNA phylogeny (excluding ambiguous mutations, that is, mutations in which there is no certainty as to the identity of the nucleotide changes). All sequences and their accession numbers, sequence alignment files, scripts, phylogenetic analysis, and sequences groups are available as [supplementary data](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online.

Identifying Nodal Mutational Events
-----------------------------------

For the purposes of the current study and for the sake of simplicity, a mutational event was considered to be "nodal" only when fulfilling two criteria: 1) the mutation in a given mtDNA lineage should be shared by at least five sequences within this lineage/sub lineage (i.e., phylogenetic node). 2) These sequences should comprise at least 85% of all clustered sequences within the studied tree node. This proportion was calculated as follows: the average proportion of sequences within branches throughout the tree that were in agreement with criterion "1" was 95 ± 12%. We chose to use a proportion within one SD of this mean. Therefore, taken together, we defined a "nodal mutation" as a mutation shared by at least five sequences comprising at least 85% of the sequences within a given branch. Accordingly, RNMs were defined as mutations that lie in the stems of at least two unrelated tree nodes, following the principles of parsimony. Notably, although we are aware of the fact that mutations occur in the branch leading to a node rather than in the base of a given node, for the sake of simplicity we used the term "nodal mutations" as outlined earlier. Additionally, a mutation could occur in a branch leading to a phylogenetic node yet only became "nodal" in a particular subnode.

Assessing the Functional Potential of Nonsynonymous Mutations
-------------------------------------------------------------

Two basic measurements were performed to assess the functional potential of all the mutations in mtDNA-encoded protein-coding genes. We calculated the Conservation Index ([@evt058-B17]) and the SIFT pathogenicity score (<http://sift.bii.a-star.edu.sg/>, last accessed April 22, 2013) ([@evt058-B26]) of amino acid substitutions. In both tests, we generated sequence alignment files (T-Coffee, with minor manual corrections) using orthologous sequences from 296 mammalian species for each of the 13 mtDNA-encoded protein genes ([supplementary table S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online, NCBI-Organelle Genome Resources). As previously suggested ([@evt058-B26]), SIFT pathogenicity scores ≤ 0.05 were considered as having the highest deleterious potential. The Conservation Index was calculated by ConSurf ([consurf.tau.ac.il](http://consurf.tau.ac.il), last accessed April 22, 2013) ([@evt058-B17]) with the Evolutionary Substitution Model, that is, mtREV for mitochondrial proteins using default settings. Conservation Index scores *X* ≥ 7 were considered as having the highest functional potential, being within 1SD from the mean Conservation Index scores of mtDNA disease-causing mutation (8.4 ± 1.8, see also results). The pathogenicity scores of amino acid substitutions were calculated using SIFT, based on the aforementioned multiple sequence alignment files. Two additional functionality measurements were applied to all nonsynonymous nodal mutations: MutPred general score ([@evt058-B29]) and Panther P-deleterious score ([@evt058-B58]) using the default cutoff values (MutPred \> 0.5, Panther \> 0.5). The resulting values were compared with those obtained from mtDNA disease-causing mutations (discussed later).

Assessing the Functional Potential of Synonymous Mutations
----------------------------------------------------------

To assess the functional potential of "nodal" synonymous mutations, we estimated codon bias. The effective number of codons (NC) ([@evt058-B67]), the GC content within the third codon position (i.e., GC3s) and the Codon Adaptation Index (CAI) ([@evt058-B51]) were calculated using CodonW ([codonw.sourceforge.net](http://www.codonw.sourceforge.net), last accessed April 22, 2013). Calculations were applied to all the observed codons in all protein-coding genes in our entire data set of 9,862 whole human mtDNA sequences. The CAI values were used to calculate the difference before and after the mutation occurrence as follows: ΔCAI of a given synonymous mutation equals CAI value after the synonymous mutational event minus the CAI value before the mutation occurred.

Assessing the Functional Potential of Mutations in RNA Genes
------------------------------------------------------------

### 1. Assessing Conservation Indexes of Mutations in RNA Genes {#SEC1}

Evolutionary conservation was previously used to evaluate the functionality of human mtDNA variants within RNA genes ([@evt058-B45]). To calculate the Conservation Index of mutations identified in each of the 22 mtDNA-encoded tRNA genes, multiple sequence alignment files were retrieved from the Mamit-tRNA website ([mamit-trna.u-strasbg.fr](http://mamit-trna.u-strasbg.fr), last accessed April 22, 2013) using sequence orthologs from at least 114 mammalian species and analyzed by ConSurf (using default settings for nucleotide sequences). To calculate the Conservation Index for mutations in the two mtDNA-encoded rRNA genes (*12S* and *16S*), we used orthologous sequences from 296 mammalian species ([supplementary table S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online, NCBI-Organelle Genome Resources) aligned by ClustalW (default settings). Conservation Index values were calculated using the Rate4Site application, a stand-alone program within the ConSurf server, using default settings for nucleotide sequences.

### 2. Assessing the Potential Structural Impact of Mutations in RNA Genes {#SEC2}

The potential effect of a given variant on structure stability within rRNA and tRNA genes (free energy, Δ*G*) was assessed using the RNAeval application of the Vienna RNA Package (version 1.8.5, [www.tbi.univie.ac.at/RNA/](www.tbi.univie.ac.at/RNA/), last accessed April 22, 2013). This application evaluates the free energy of an RNA molecule in a fixed secondary structure, excluding "pseudoknots," which are RNA structures that are composed of two helical segments at least, connected by single-stranded regions or loops ([@evt058-B53]). For analysis of tRNA genes, we retrieved the RNA structures from the Mamit-tRNA website ([mamit-trna.u-strasbg.fr/](http://mamit-trna.u-strasbg.fr/), last accessed April 22, 2013), while rRNA gene structures were retrieved from the CRW website ([www.rna.icmb.utexas.edu/](www.rna.icmb.utexas.edu/), last accessed April 22, 2013). For the latter website, the *12S rRNA* structure was retrieved from the "Current *12S rRNA* Structures" section and the *16S rRNA* was retrieved from the "Appendix to a large rRNA folding manuscript" section. We calculated ΔG by subtracting the assessed free energy of an RNA variant before the mutational event from the assessed free energy in the sequence harboring the mutation. Absolute values were used, because we were merely interested in the magnitude of the effect on structural stability.

### 3. Novel RNA-Mutation Scoring Method to Assess Functionality {#SEC3}

As mentioned earlier, two measurements were performed to assess the functional potential of mutations within RNA-coding genes, namely assessment of the Conservation Index and calculation of the potential free energy change before and after the mutation (Δ*G*). In general, mutations in stems within stem-and-loop elements of RNA molecules can alter structural stability (Δ*G*). However, such mutations are not necessarily evolutionarily conserved as a result of compensatory mutations. Moreover, evolutionarily conserved mutations could be found in loops, having little or no predicted effect on structures. Therefore, a simple compilation of the two tests could easily lead to contrasting results. To overcome this obstacle, we formulated a scoring method lending equal weight to the results obtained from each test. To this end, the obtained values were transformed to scales of arbitrary units ranging from 1 to 9: 1) as already formulated in ConSurf, for the Conservation Index, the value "1" represented the most variable site and "9" the most conserved site. 2) For the Δ*G* test, the value "1" represented a lack of effect and "9" represented the largest effect on structural stability. Specifically, the score "9" is assigned to the greatest change in Δ*G* observed in the analysis within a studied gene or in disease-causing mutations. The combined RNA score is calculated as follows: RNA score = Conservation Index + Δ*G* index, yielding values ranging from 2 to 18. The resulting values were compared with those obtained with mtDNA disease-causing mutations (discussed later).

mtDNA Disease-Causing Mutations
-------------------------------

To assess the functional potential of the phylogenetic variants considered, we sought a set of mutations with experimentally verified functionality. To this end, we applied the earlier-described tests of functionality to a set of mtDNA disease-causing mutations, of which 38 were nonsynonymous and 27 were in RNA genes. These mutations comprise all confirmed disease-causing mutations listed by MITOMAP, that is, were found in patients but not in controls in at least two independent studies (26 confirmed nonsynonymous and 27 RNA genes mutations, [www.mitomap.org](www.mitomap.org), last accessed April 22, 2013) in addition to 12 nonsynonymous mutations that were identified in patients and were experimentally verified for their functionality (listed by [@evt058-B44]) ([supplementary tables S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) and [S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online).

Statistics
----------

To compare the results obtained from the earlier described tests of functionality between nodal mutations and disease-causing mutations, we performed a Mann--Whitney *U* test and a resampling simulation with sequential Bonferroni correction (discussed later) for multiple testing. We preformed resampling analyses, which control for differences in sample size of the different subsets of mutations ([@evt058-B52]; [@evt058-B18]) to determine the portion of nodal mutations in RNA genes that are most similar to the disease-causing mutations. The detailed procedure is describes in [supplementary figure S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online. Briefly, each set of mutations was sorted according to functionality score. The different percentile of each set of mutations was tested against that of documented disease-causing mutations. Significant levels were adjusted for multiple tests, using a sequential Bonferroni correction ([@evt058-B43]). We used *R* × *C* (rows × columns) test of independence to test for differences in the frequency of mutations that passed the functionality test cutoff values in SNMs and RNMs as compared with disease causing mutations.

Results
=======

Identifying Single and Recurrently Nodal Mutations in the Human mtDNA Phylogeny
-------------------------------------------------------------------------------

We first sought to identify all of the mutational events that occurred during human mtDNA phylogeny. To this end, we constructed a phylogenetic tree from 9,868 publicly available whole mtDNA sequences ([supplementary fig. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online), including a nonredundant set of 9,862 whole human mtDNA sequences and six Neanderthal mtDNA sequences ([supplementary table S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online). Indeed, the resulting tree topology closely resembled that of recently published human mtDNA trees ([@evt058-B47]; [@evt058-B62]; [@evt058-B2]).

As the topology of our phylogenetic tree was consistent with previous studies, we extensively analyzed the tree to identify all variants encompassing mutations that lie at the base of certain branches (nodal mutations), as well as RNMs. It is noteworthy that recording of all variants was not conducted by comparison with a common reference sequence, such as the rCRS (revised Cambridge Reference Sequence), but rather by comparing the premutation node with the branch in which that mutation occurred. Our screen revealed 31,714 mutational events, of which 4,176 defined phylogenetic branches (nodal mutations). Of these, 1,606 lie in the stem of single phylogenetic branches (SNMs), and 2,570 mutational events occurred in the stem of two or more parsimoniously unrelated tree branches; the latter inhabit 679 nucleotide positions (i.e., 679 RNMs) ([supplementary table S5](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online). Out of the total number of RNMs, 188 were either nonsynonymous (*N* = 121 RNMs, encompassing 357 mutational events) or RNA gene mutations (*N* = 67 RNMs, encompassing 219 mutational events). It is expected that if human mtDNA mutates at random, then the mutational proportion in noncoding sequences should be comparable with the proportion of such sequences in the human mitochondrial genome, that is, approximately 7%. In contrast, we found that noncoding mtDNA sequences harbored 35.8% of the total observed nodal mutations (including both RNMs and SNMs) and 49% of the RNMs, that is, 5-fold (χ^2^ test, *P* \< 0.001) and 7-fold (χ^2^ test, *P* \< 0.001) more than expected at random, respectively. This indicates the existence of strong purifying selection against the transmission of nodal mutations in coding mtDNA sequences and even stronger selective constraint acting upon RNMs.

Assessing the Functional Potential of Nonsynonymous RNMs and SNMs
-----------------------------------------------------------------

Previously, two tests were used to assess the functionality of nonsynonymous mtDNA variants, that is, evolutionary conservation ([@evt058-B34]; [@evt058-B44]) and SIFT pathogenicity score ([@evt058-B41]). In our analysis, we have calculated the Conservation Index and SIFT scores for all the nonsynonymous mutation. These tests are not redundant but rather complementary, because a given mutation may alter a highly conserved position yet did not radically change the physical--chemical properties of the amino acid, and vice versa. In consistence with previously published results ([@evt058-B57]; [@evt058-B41]), a comparison of the Conservation Index distribution of nonsynonymous mutation in general as well as those that passed the SIFT pathogenicity score cutoff threshold (*X* ≤ 0.05) revealed that nodal mutations had significantly lower Conservation Index than either disease-causing mutations (Mann--Whitney *U* test, *P* \< 0.001) or mutations occurring at the tips of the tree (Mann--Whitney *U* test, *P* \< 0.05, [fig. 1](#evt058-F1){ref-type="fig"}*A* and *B*). RNMs had the lowest Conservation Index, thus suggesting stronger negative selection acting against RNMs in particular. F[ig]{.smallcaps}. 1.---Comparison of functionality assessments of nonsynonymous and RNA genes mutations to disease causing and tips mutations. (*A*) The distribution of Conservation Index scores of nonsynonymous mutations in the tree Tips, SNMs, RNMs, and of disease-causing mutations. (*B*) The distribution of Conservation Index scores of nonsynonymous mutations, which also passed the SIFT score cutoff (X ≤ 0.05) in the tree Tips, SNMs, RNMs, and of disease-causing mutations. (*C*) The percentage of nonsynonymous mutations (SNMs, RNMs, and disease-causing mutations) that passed the threshold of SIFT, the Conservation Index as well as the cutoff value of either MutPred or Panther. Total number of mutations is indicated for each category of tested mutations. (*D*) The score distribution of RNA genes mutations in the tree Tips, SNMs, RNMs, and of disease-causing mutations. \*\*\*Significant difference between the disease-causing mutations to the Tips, SNMs, or RNMs (Mann--Whitney *U* test, *P* \< 0.001).

We next asked whether a subset of the nodal mutations (RNMs and SNMs) have a high functional potential, and hence are candidates to be positively selected. As confirmed mtDNA disease-causing mutations are clearly functional (38 nonsynonymous mutations, [supplementary table S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online), we calculated their scores using the earlier-mentioned tests (i.e., Conservation Index and SIFT scores) and used them as a reference of functionality to compared with our identified RNMs and SNMs. We further augmented our analysis by two additional functionality assessment tools, MutPred, and Panther, which were recently reported to perform well in comparison with other available assessment methods ([@evt058-B59]). First, our analysis validated the use of the disease-causing mutations as a reference for functionality as approximately 92% of these mutations not only passed the functionality threshold of SIFT and had a high Conservation Index (8.4 ± 1.8) but also passed at least one additional test---either MutPred or Panther ([fig. 1](#evt058-F1){ref-type="fig"}*C*). Second, our results indicate that most of the 121 nonsynonymous RNMs or 283 SNMs (91% and 85%, respectively), did not pass the thresholds as explained for disease-causing mutations and in that are significantly different from the latter (*R* × *C* \[rows × columns\] test of independence, *G* = 108.85, df = 2, *P* \< 0.001). Thus, along with the observed overrepresentation of nodal mutations in noncoding sequences, and the differences from the tip mutations our results suggest stronger selective constraints acting on nodal mutations. However, 11 out of the 121 nonsynonymous RNMs and 42 out of the 283 nonsynonymous SNMs passed the functionality score threshold of SIFT, had comparable Conservation Index with disease-causing mutations (i.e., within 1SD from the mean ConSurf values of disease-causing mutations), and passed at least one additional test (MutPred or Panther), similarly to the disease-causing mutations. We thus interpret these particular nonsynonymous RNMs and SNMs as the best candidates to bare adaptive properties.

Assessing the Functional Potential of Synonymous Nodal Mutations
----------------------------------------------------------------

Synonymous mutations may have functional consequences because of selective constraints acting on certain codons ([@evt058-B9]). Codon bias (i.e., nonrandom codons usage) in highly expressed genes may reflect their adaptation toward translational efficient codons due to the abundance of their associated tRNAs ([@evt058-B22]; [@evt058-B49]). We used our 9,862 whole human mtDNA sequence data set to calculate the effective number of used codons (NC) for each amino acid in each studied protein-coding gene ([@evt058-B67]). NC values range from 20 to 61, for example, from the usage of a single effective codon per amino acid to equal abundance of all codons. We found that the mtDNA NC values ranged from 31 (ND3) to 41 (COX2), thus reflecting moderate codon bias, which differs among mtDNA genes. NC-plot analysis ([@evt058-B67]) excluded the possibility that certain transitions or transversions at the third codon position are responsible for the observed codon bias (GC3s) ([supplementary fig. S4*A*](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online, χ^2^ test, *P* \< 0.001). Next, we have calculated the CAI ([@evt058-B51]) in all mtDNA genes. In brief, CAI measures how the codon usage of a given gene resembles the codon usage of the most highly expressed genes, because the latter are the most likely to adapt toward using translational efficient codons. While inspecting recently published human mtDNA transcriptome data of 16 human tissues ([@evt058-B33]), we identified ND3, the concatenate of ND4 and ND4L, COX3 and CYTB as the most highly expressed mtDNA transcripts. Our analysis revealed a correlation between the relative expression of mtDNA genes and their CAI values, after correction for peptide length (CAI/amino acid length). Using each of the four highly expressed genes as references for the CAI calculation, produced similar correlation whereas the highest correlation was obtained using either CYTB or the concatenated gene ND4\\ND4L as references ([supplementary fig. S4*B*](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online, *r* = 0.67, *P* = 0.024 and *r* = 0.68, *P* = 0.021, respectively). Excluding the ND4\\ND4L concatenate from the correlation analysis revealed even higher correlation of the remaining mtDNA genes ([supplementary fig. S4C](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online, *r* = 0.84, *P* = 0.0024). Therefore, for the sake of simplicity, we used CYTB as a single reference for further CAI calculations. As adaptation toward translational efficiency is correlated with tRNA abundance, we examined which are the most frequently used codons in the highly expressed CYTB gene as compared with the expected random codons usage (equal distribution). We identified 28 codons that are used significantly more than expected by chance (*P* \< 0.01, two way χ^2^ test), of which 19 correspond to the mtDNA-encoded tRNAs, which is significantly more than expected by chance (χ^2^ test, *P* \< 0.001). Accordingly, a recent study showed higher abundance of mtDNA-encoded tRNAs in the mitochondria as compared with imported tRNAs ([@evt058-B33]). These findings further support the notion that CYTB adapted toward using more translational efficient codons. We next estimated the functional potential of mtDNA synonymous mutations by calculating the difference in CAI values before and after the occurrence of each identified nodal synonymous mutation (i.e., ΔCAI) using CYTB as a reference ([supplementary table S5](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online). While comparing the distribution of ΔCAI values between either SNMs or RNMs to tree tips mutations, we found significant differences ([fig. 2](#evt058-F2){ref-type="fig"}, Mann--Whitney *U* test, *P* \< 0.001). Nevertheless, whereas the SNMs showed general reduction in values, the RNMs showed the opposite trend ([fig. 2](#evt058-F2){ref-type="fig"}). Hence, our analysis did not detect consistent selective signature among nodal synonymous mutations. Moreover, in the absence of mtDNA disease-causing synonymous mutations, there is no set of clearly functional synonymous mutations to be used as a "functionality reference" of CAI values. F[ig]{.smallcaps}. 2.---Comparison of functionality assessments of synonymous mutations. The distribution of ΔCAI values of synonymous mutations in the tree Tips, SNMs, and RNMs. \*\*\*Significant difference between the Tips to the SNMs or RNMs (Mann--Whitney *U* test, *P* \< 0.001).

Identifying Nodal Mutations with Functional Potential in RNA Genes
------------------------------------------------------------------

Similar to the analysis of nonsynonymous mutations, we compared the sequence attributes of RNMs and SNMs in mtDNA-encoded RNA genes (tRNAs and rRNA genes) with those of disease-causing mutations in the same genes. As RNA genes are not translated, we generated a novel combined test which takes into account evolutionary conservation and the potential effect of the tested mutation on the predicted structural stability of the molecule (Δ*G*) (see Materials and Methods). Our novel RNA mutations functionality scoring method was applied to 27 disease-causing mutations in RNA genes ([supplementary table S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online) and used as a reference upon assessment of the functional potential of RNMs and SNMs. As observed in the distribution of nonsynonymous functionality scores, the RNA scores of RNA nodal mutations (i.e., either RNMs or SNMs, [fig. 1](#evt058-F1){ref-type="fig"}*D*) had significantly lower values than that of disease-causing mutations (Mann--Whitney *U* test, *P* \< 0.001). However, only SNMs also had significantly lower values than mutations occurring at the tips of the tree (Mann--Whitney *U* test, *P* \< 0.01). To identify the group of nodal mutations that possesses comparable functionality values with those of disease-causing mutations, we used resampling simulations with sequential Bonferroni correction for multiple testing (see Materials and Methods). This approach revealed that for RNMs in RNA genes (*N* = 67), the upper 20th percentile (13 mutations), lost its statistical significance and therefore had functionality values (RNA mutations functionality scores) comparable with those of disease-causing mutations ([supplementary table S6*A*](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online). Additionally, using the resampling simulations analysis, we detected that the upper 11th percentile subset of SNMs in RNA genes (25 mutations), lost its statistical significance making them the RNA genes' SNMs with functionality values most similar to those of disease-causing mutations ([supplementary table S6*B*](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online).

The "functional" RNMs Associate with Phenotypes
-----------------------------------------------

Taken together, 24 RNMs and 67 SNMs (nonsynonymous and RNA genes mutations) had comparable functionality values with those of disease-causing mutations ([tables 1](#evt058-T1){ref-type="table"} and [2](#evt058-T2){ref-type="table"} and [supplementary table S7](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online). For the sake of brevity, we refer to these as "functional" RNMs and SNMs. Our analysis indicated that RNMs were subjected to the strongest negative selection during human evolution. As mentioned earlier, we hypothesized that the RNMs with the highest functional potential are the best candidates to possess adaptive properties. An outcome of this possibility is that the very same RNMs could associate with diseases if the environment changes. Indeed, the environment and climate dramatically changed during the course of human evolution. Thus, we asked whether our discovered "functional" RNMs associate with known diseases from the one hand or were reported to be adaptive to certain environments from the other. Firstly, an inspection of the phylogenetic distribution of our identified 24 "functional" RNMs revealed their occurrence throughout human mtDNA phylogeny ([fig. 3](#evt058-F3){ref-type="fig"}). These RNMs are also found throughout the human mitochondrial genome, albeit with no clear preference for particular genes ([fig. 4](#evt058-F4){ref-type="fig"}). Second, we screened the literature and found reports showing that lineages harboring our identified RNMs were associated with altered tendencies to develop genetic disorders ([table 3](#evt058-T3){ref-type="table"}). Some lineages that share such RNMs were also associated with the same phenotypes. Of particular interest is the T3394C variant ([table 1](#evt058-T1){ref-type="table"}, mutation number 1), identified as nodal in lineages J1c1 and M9a. These lineages were independently identified as modifying the phenotypic expression of Leber Hereditary Optic Neuropathy (LHON) ([@evt058-B6]; [@evt058-B31]; [@evt058-B68]). Moreover, recent studies have shown that the T3394C variant is enriched in haplogroup M9 within the high altitude Tibetan population ([@evt058-B19]; [@evt058-B23]) and affects mitochondrial function in cybrids ([@evt058-B23]). F[ig]{.smallcaps}. 3.---Distribution of recurrent nodal mutational events with functional potential across human mtDNA phylogeny. A neighbor-joining phylogenetic tree of whole human mtDNA sequences was created using MEGA5 (see Materials and Methods). The tree was generated from 563 ancestral sequences representing 9,868 sequences clustered according to previously published nomenclature ([@evt058-B2]; [@evt058-B62]). The mutation numbers are correlated with those listed in [tables 1--3](#evt058-T1 evt058-T2 evt058-T3){ref-type="table"} and [figure 4](#evt058-F4){ref-type="fig"}. Arrowheads indicate the branch at which the mutational events occurred. Arrowheads pointing to the terminal nodes refer to mutational events that lie in the stem of a subnode of the indicated ancestral sequence. F[ig]{.smallcaps}. 4.---Distribution of RNM events with functional potential across human mtDNA. The mutation numbers are correlated with those listed in [tables 1--3](#evt058-T1 evt058-T2 evt058-T3){ref-type="table"} and [figure 3](#evt058-F3){ref-type="fig"}. The bars in the inner circle represent the locations of tRNA genes, whereas the bars in the middle circle represent the locations of the rRNA and protein-coding genes. The stripes in the outer circle and the arrowhead mark the location of the mutational events. Table 1Summary of Nonsynonymous RNMs Events Having Functional Potential[^a^](#evt058-TF1){ref-type="table-fn"}Mutation NumbermtDNA MutationHaplo-GroupNumber of SequencesHaplo-GroupNumber of SequencesGeneAmino Acid ChangeConservation IndexSIFT ScorePANTHER *P* DeleteriousMutPred1T3394CJ1c1[^b^](#evt058-TF2){ref-type="table-fn"}45M9a[^b^](#evt058-TF2){ref-type="table-fn"}101*ND1*Y30H80.020.390.732A3547GB2[^b^](#evt058-TF2){ref-type="table-fn"}57within HV1b^b^9*ND1*I81V80.010.290.573T3644CWithin M13[^b^](#evt058-TF2){ref-type="table-fn"}11D4h[^b^](#evt058-TF2){ref-type="table-fn"}56*ND1*V113A90.010.490.804[^c^](#evt058-TF3){ref-type="table-fn"}A4917GR1a[^b^](#evt058-TF2){ref-type="table-fn"}15T[^b^](#evt058-TF2){ref-type="table-fn"}446*ND2*N150D70.060.790.58N1b2[^b^](#evt058-TF2){ref-type="table-fn"}115G7697AWithin C1d[^b^](#evt058-TF2){ref-type="table-fn"}21Within M36[^b^](#evt058-TF2){ref-type="table-fn"}6*COX2*V38I90.020.600.60Within M9a[^b^](#evt058-TF2){ref-type="table-fn"}266T8843CH45[^b^](#evt058-TF2){ref-type="table-fn"}7Within A11[^b^](#evt058-TF2){ref-type="table-fn"}8*ATP6*I106T700.800.69Within H2a5[^b^](#evt058-TF2){ref-type="table-fn"}87A10086GL3b^b^53Within W1[^b^](#evt058-TF2){ref-type="table-fn"}8*ND3*N10D80.010.530.168A11084GWithin M2a1[^b^](#evt058-TF2){ref-type="table-fn"}5Within M7a[^b^](#evt058-TF2){ref-type="table-fn"}16*ND4*T109A900.590.499G11969AC4[^b^](#evt058-TF2){ref-type="table-fn"}107M11[^b^](#evt058-TF2){ref-type="table-fn"}12*ND4*A404T70.040.910.7010C13129TWithin L0d[^b^](#evt058-TF2){ref-type="table-fn"}8N1b2[^b^](#evt058-TF2){ref-type="table-fn"}11*ND5*P265S70.030.900.7611G15119AWithin N5[^b^](#evt058-TF2){ref-type="table-fn"}5Within C1b^b^8*CYTB*A125T90.040.440.5312G15257AJ2[^b^](#evt058-TF2){ref-type="table-fn"}106Within K1b1[^b^](#evt058-TF2){ref-type="table-fn"}20*CYTB*D171N70.020.520.72[^3][^4][^5] Table 2Summary of All RNA RNMs Events Having Functional Potential[^a^](#evt058-TF4){ref-type="table-fn"}Mutation NumbermtDNA MutationHaplo-GroupNumber of SequencesHaplo-GroupNumber of SequencesHaplo-GroupNumber of SequencesGeneΔG IndexConservation IndexRNA Score13G750AH2a2[^b^](#evt058-TF5){ref-type="table-fn"}91L3e3/4/5[^b^](#evt058-TF5){ref-type="table-fn"}34*12S*18914G951AH2a1[^b^](#evt058-TF5){ref-type="table-fn"}60D3[^b^](#evt058-TF5){ref-type="table-fn"}9*12S*7.2411.215T1243CW[^b^](#evt058-TF5){ref-type="table-fn"}141L0K[^b^](#evt058-TF5){ref-type="table-fn"}7*12S*7.218.216G1719AH7a[^b^](#evt058-TF5){ref-type="table-fn"}21X2[^b^](#evt058-TF5){ref-type="table-fn"}114M28[^b^](#evt058-TF5){ref-type="table-fn"}8*16S*189Within L3h[^b^](#evt058-TF5){ref-type="table-fn"}21Within D4h[^b^](#evt058-TF5){ref-type="table-fn"}9Within P[^b^](#evt058-TF5){ref-type="table-fn"}5D6[^b^](#evt058-TF5){ref-type="table-fn"}6N1[^b^](#evt058-TF5){ref-type="table-fn"}189D4m[^b^](#evt058-TF5){ref-type="table-fn"}517T2083CWithin M40[^b^](#evt058-TF5){ref-type="table-fn"}8Within U4b^b^6*16S*3.469.418T3027CU5a1d[^b^](#evt058-TF5){ref-type="table-fn"}13E[^b^](#evt058-TF5){ref-type="table-fn"}62*16S*3.269.219G5821AC7a[^b^](#evt058-TF5){ref-type="table-fn"}15M53[^b^](#evt058-TF5){ref-type="table-fn"}11*tRNA-Cys*7.118.120T7581CWithin D4j[^b^](#evt058-TF5){ref-type="table-fn"}23Within U1[^b^](#evt058-TF5){ref-type="table-fn"}22N2a[^b^](#evt058-TF5){ref-type="table-fn"}5*tRNA-Asp*7.3613.3Within H4a[^b^](#evt058-TF5){ref-type="table-fn"}521G12236AL2b/c[^b^](#evt058-TF5){ref-type="table-fn"}43Within L5[^b^](#evt058-TF5){ref-type="table-fn"}9*tRNA-Ser(AGY)*931222A14693GY[^b^](#evt058-TF5){ref-type="table-fn"}19Within M2a1[^b^](#evt058-TF5){ref-type="table-fn"}12*tRNA-Glu*3.569.523G15927AB5b^b^14Within G3[^b^](#evt058-TF5){ref-type="table-fn"}7X2b^b^51*tRNA-Thr*6.9612.9Within HV1a[^b^](#evt058-TF5){ref-type="table-fn"}8Within U6a[^b^](#evt058-TF5){ref-type="table-fn"}2524G15928AT[^b^](#evt058-TF5){ref-type="table-fn"}442Within Z[^b^](#evt058-TF5){ref-type="table-fn"}9Within M35[^b^](#evt058-TF5){ref-type="table-fn"}18*tRNA-Thr*8.319.325A15951GD4b1[^b^](#evt058-TF5){ref-type="table-fn"} + D3[^b^](#evt058-TF5){ref-type="table-fn"}33Within L0d[^b^](#evt058-TF5){ref-type="table-fn"}8*tRNA-Thr*1.978.9[^6][^7] Table 3Summary of All RNM Association to Phenotype Events Having Functional Potential[^a^](#evt058-TF6){ref-type="table-fn"}Mutation NumbermtDNA MutationHaplo-GroupsPhenotypeReferences1T3394CJ1c1[^b^](#evt058-TF7){ref-type="table-fn"}1. LHON in haplogroups M9 and J1c1 2. Adaptation to high altitude in M91. [@evt058-B6]; [@evt058-B31]; [@evt058-B68]M9a[^b^](#evt058-TF7){ref-type="table-fn"}[@evt058-B19]; [@evt058-B23]3T3644CWithin M13[^b^](#evt058-TF7){ref-type="table-fn"}Bipolar disorder in patients vs. controls[@evt058-B38]D4h[^b^](#evt058-TF7){ref-type="table-fn"}4[^c^](#evt058-TF8){ref-type="table-fn"}A4917GR1a[^b^](#evt058-TF7){ref-type="table-fn"}1. Age-related macular degeneration in patients vs. controls/reduced sperm motility in haplogroup T 2. Coronary-artery disease and diabetic retinopathy association haplogroup T 3. Altered susceptibility to the common complications of T2DM in haplogroup N1b1 (N1b2)1. [@evt058-B5] 2. [@evt058-B46] 3. [@evt058-B14]; [@evt058-B25]T[^b^](#evt058-TF7){ref-type="table-fn"}N1b2[^b^](#evt058-TF7){ref-type="table-fn"}19G5821AC7a[^b^](#evt058-TF7){ref-type="table-fn"}Enhanced penetrance of hearing loss in Chinese families[@evt058-B32]M53[^b^](#evt058-TF7){ref-type="table-fn"}5G7697AWithin C1d[^b^](#evt058-TF7){ref-type="table-fn"}Hypertrophic cardiomyopathy (HCM) in patients vs. controls in Chinese families[@evt058-B66]Within M36[^b^](#evt058-TF7){ref-type="table-fn"}Within M9a[^b^](#evt058-TF7){ref-type="table-fn"}7A10086GL3b^b^African Americans with hypertension-associated end-stage renal disease in patients vs. controls[@evt058-B65]Within W1[^b^](#evt058-TF7){ref-type="table-fn"}8A11084GWithin M2a1[^b^](#evt058-TF7){ref-type="table-fn"}1. Mitochondrial Encephalopathy Lactic Acidosis and Stroke-like Episodes (MELAS)1. [@evt058-B27]Within M7a[^b^](#evt058-TF7){ref-type="table-fn"}2. Parkinson's disease (PD) in Japanese individuals2. [@evt058-B55]21G12236AL2b/c[^b^](#evt058-TF7){ref-type="table-fn"}Maternally inherited nonsyndromic hearing impairment in haplogroup H (The G12236A mutation)[@evt058-B28]Within L5[^b^](#evt058-TF7){ref-type="table-fn"}22A14693GY[^b^](#evt058-TF7){ref-type="table-fn"}1. Modulating the phenotypic manifestation of deafness-associated A1555G mutation in Chinese families. 2. Modulating the manifestation of LHON G3460A mutation in a Chinese family. 3. Associates with MELAS.1. [@evt058-B12]; [@evt058-B32]2. [@evt058-B60]Within M2a1[^b^](#evt058-TF7){ref-type="table-fn"}3. [@evt058-B61]12G15257AJ2[^b^](#evt058-TF7){ref-type="table-fn"} Within K1b1[^b^](#evt058-TF7){ref-type="table-fn"}1. Association of mitochondrial haplogroup J2 with longevity and reduced mtDNA oxidative damage in high altitude Pyrenees Mountains population. 2. Association of G15257A with LHON.[@evt058-B4]; [@evt058-B13]; [@evt058-B39]23G15927AB5b^b^1. Enhanced penetrance of hearing loss in Chinese families with haplogroup B5b and the pathological mutation A1555G. 2. Haplogroup B5b over representation in Japanese centenarians, Parkinson's and type 2 diabetic patients. 3. Haplogroup X2 is associated with centenarians in the Amish.1. [@evt058-B10]; [@evt058-B64] 2. [@evt058-B55] 3. [@evt058-B11]Within G3[^b^](#evt058-TF7){ref-type="table-fn"}X2b^b^Within U6a[^b^](#evt058-TF7){ref-type="table-fn"}Within HV1a[^b^](#evt058-TF7){ref-type="table-fn"}24G15928AT[^b^](#evt058-TF7){ref-type="table-fn"}1. Association with idiopathic repeated pregnancy loss. 2. Protection against Alzheimer Disease in French Canadians.1. [@evt058-B50] 2. [@evt058-B8]Within Z[^b^](#evt058-TF7){ref-type="table-fn"}Within M35[^b^](#evt058-TF7){ref-type="table-fn"}25A15951GD4b1[^b^](#evt058-TF7){ref-type="table-fn"} + D3[^b^](#evt058-TF7){ref-type="table-fn"}Influences phenotypic expression of LHON-associated G11778A mutation in a Chinese family[@evt058-B30]within L0d[^b^](#evt058-TF7){ref-type="table-fn"}[^8][^9][^10]

Discussion
==========

In this study, we conducted a comprehensive analysis of the entire human mtDNA phylogeny and identified 188 RNMs and 518 SNMs that were either nonsynonymous (*N* = 121 and *N* = 283, respectively) or RNA gene mutations (*N* = 67 and *N* = 235, respectively). As intuitively expected both RNMs and SNMs, exhibited significantly different functional attributes from disease-causing mutations. Strikingly, 24 RNMs (11 nonsynonymous and 13 RNA mutations) and 67 SNMs (42 nonsynonymous, 25 RNA mutations) displayed comparable functionality values with those of disease-causing mutations. This implies the strong functional potential of these particular nodal mutations.

While analyzing nodal synonymous mutations in the human phylogeny, we identified preference of mtDNA protein-coding genes for codons recognized by mtDNA-encoded tRNAs rather than imported tRNAs. This most likely reflects adaptation toward using more translational efficient codons in the mitochondria. However, no apparent trend was observed in the distribution of the functional potential values of synonymous mutations (ΔCAI) as compared between all types of nodal mutations (SNMs and RNMs) and tree tips mutations. Therefore, assessment of the functional potential of nodal synonymous mutations still awaits the identification of disease causing synonymous mtDNA mutations for comparison.

Previously, several studies including those performed by us showed that nearly a quarter of the nodal mutations in the human mitochondrial phylogeny that occurred within the coding mtDNA region had similar characteristics to disease-causing mutations, and thus reflecting positive selection ([@evt058-B44]). Since nodal mutations, in general, and functional RNMs or SNMs, in particular, have been retained in the human population over a prolonged period, it is logical to assume that they survived the effects of natural selection. Although mtDNA disease-causing mutations recur multiple times independently in unrelated families, such mutations mostly associate with the terminal tips of the phylogenetic tree, most likely due to strong negative selection. This is in sharp contrast to the "functional" RNMs and SNMs. Although such mutations share many characteristics with disease-causing mutations, they are detected within the stems of certain phylogenetic branches, survived natural selection and thus have likely been positively selected ([@evt058-B44]; [@evt058-B45]). Nevertheless, we cannot exclude the possibility that some RNMs or SNMs survived natural selection because they were only mildly deleterious and had only little effect on fitness.

The functional RNMs caught our attention, because they could, in principle, be involved in events of convergent evolution. As the functional RNMs are positively selected and hence adaptive, they likely played a role in human survival in the face of past environmental conditions. As the environment and life style of modern humans have dramatically changed with time and as modern humans reach much older ages than did our ancestors, it is expected that some functional RNMs would alter susceptibility to disease or age-related phenotypes. Indeed, the identities of some functional RNMs support this hypothesis, as these RNMs reside in the stem of unrelated mtDNA haplogroups that independently associate with altered susceptibility to complex and mitochondrial genetic disorders. Interestingly, our literature search revealed that in some cases the mtDNA haplogroups that share RNMs also alter the susceptibility to the same diseases ([table 3](#evt058-T3){ref-type="table"}). As the RNMs are the only "functional" mutations shared among these haplogroups, it is tempting to suggest that these RNMs played important roles in the molecular basis of these phenotypes.

If certain RNMs associate with altered susceptibility to the same phenotypes in unrelated lineages in modern times, then one can ask whether it is possible that these very mutations reflect similar adaptive properties of these unrelated lineages, namely reflecting convergent adaptive evolution? Naturally, disease association underlines the functional properties of a given mutation but does not readily lend clues to the exact adaptive role of that mutation in our phylogenetic history. Moreover, association with age-related diseases is typically invisible to selection due to the onset of such conditions after reproductive age. Previously, we showed that certain nodal mutations in our phylogenetic history associated with the ability of our ancestors to survive in different climatic conditions, mainly due to an altered balance between heat and ATP production, that is, coupling efficiency ([@evt058-B36]). As "functional" RNMs occur in unrelated lineages from different ethnicities that frequently inhabit different parts of the globe, it is less obvious how to assess shared adaptive properties. Nevertheless, recent studies have shown that the mtDNA variant, T3394C (a "functional" RNM, which is nodal in lineages J1c1 and M9a; [table 1](#evt058-T1){ref-type="table"}, mutation number 1), is enriched in haplogroup M9 within the high altitude Tibetan population ([@evt058-B19]; [@evt058-B23]) and affects mitochondrial function in cybrids ([@evt058-B23]). As mentioned earlier, the same RNM (T3394C) associated with increased risk for LHON. Hence, RNMs that played adaptive role during the phylogenetic history of our kind alter susceptibility to disease in modern times, given that environmental conditions have since changed dramatically.

Similar to the T3394C RNM, the RNM G15927A ([table 2](#evt058-T2){ref-type="table"}, mutation number 23) that was identified as nodal in lineages B5b, a sub-lineage of G3, a sub-lineage of U6a, a sub-lineage of HV1a, and X2b associated with longevity in the frame of two of these lineages, that is, B5b ([@evt058-B55]) and X2 ([@evt058-B11]). However, low resolution of the X2 haplogroup assignment in the latter study prevented us from drawing more conclusive phenotypic association of the G15927A variant. Thus, to better understand the functional potential of nodal mutations (both RNMs and SNMs) future mtDNA disease-association studies will benefit from higher resolution of haplogroup assignment.

Clearly, mtDNA variants are not sufficient to cause a phenotype, mainly because mitochondrial functions operate via mitochondrial--mitochondrial and nuclear--mitochondrial epistatic interactions, thus calling for modifying compensatory mutations ([@evt058-B21]). As such, it is predicted that mutations with functional properties will associate with different phenotypes or with varying phenotypic severity/expression in different genetic backgrounds. Functional RNMs are no exception in this matter. The mtDNA RNM A4917G ([table 1](#evt058-T1){ref-type="table"}, mutation 4) that was identified as nodal in the mtDNA haplogroups T and N1b2 associated with two different phenotypes. Specifically, haplogroup T associated with reduced sperm motility ([@evt058-B46]), and haplogroup N1b2 (sometimes termed N1B1), associated with altered susceptibility to common complications of type 2 diabetes mellitus ([@evt058-B14]). Hence, although exhibiting clear characteristics of functional potential, some "functional" mtDNA RNMs are instead expected to exhibit their phenotypic effect only in combination with other factors, suggesting variability in the degree of functionality among RNMs.

Our detailed analysis of RNMs over the entire human mtDNA phylogeny, including those with functional potential, became possible due to a novel in-house-developed bioinformatics tool entitled FuRNED (Functional Recurrent Nodal Events Detector). This tool associated genetic variants with specific lineages in the human mtDNA phylogeny and assessed the functional potential of coding region mutations. The scripts of this tool are available as [supplementary data](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) online.

Conclusions
===========

In summary, we have analyzed and identified the largest set of rare and common variants in the human mtDNA phylogeny to date, including single and recurrent nodal variants (SNMs and RNMs, respectively). A novel in-house developed bioinformatics tool enabled identification of SNMs and RNMs that exhibit similar characteristics as do disease-causing mutations, yet unlike the latter, survived natural selection over time and hence, are likely adaptive. As some of the functional RNMs became independently nodal in unrelated mtDNA lineages that associate with the same traits and diseases, it is possible that such mutations are major players in assigning the traits in question, thus providing a novel explanation for the molecular basis of such phenotypes. From the evolutionary perspective, these RNMs potentially share common functionality in unrelated lineages and thus constitute the best candidates to play an adaptive role in a convergent manner during human phylogentic history. To our knowledge, this is the most comprehensive analysis of selective signatures within human mtDNA-encoded RNA and protein genes. For the first time, we discover virtually all positively selected SNMs and RNMs in our phylogeny while emphasizing their dual role in evolution and disease etiology today.

Supplementary Material
======================

[Supplementary data and figures S1--S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) and [tables S1--S7](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evt058/-/DC1) are available at *Genome Biology and Evolution* online (<http://www.gbe.oxfordjournals.org/>).

###### Supplementary Data

This work was supported by the Israeli Science Foundation grant 387/08 to D.M and a partial Kreitman scholarship for excellent graduate students (BGU) awarded to L.L.

[^1]: **Data deposition:** This article constitutes an analysis of sequences that are already available in GenBank. Accession numbers are mentioned within the text.

[^2]: **Associate editor:** Judith Mank

[^3]: ^a^Summary of all RNM events detected in the phylogenetic analysis bearing functional potential (see Materials and Methods).

[^4]: ^b^Group of sequences with the same lineage nomenclature; "within"---the mutational event occurred or became "nodal" inside a phylogenetic branch.

[^5]: ^c^Mutation number 4 did not pass the SIFT score cutoff (see main text).

[^6]: ^a^Summary of all RNM events detected in the phylogenetic analysis bearing functional potential (see Materials and Methods).

[^7]: ^b^Group of sequences with the same lineage nomenclature; "within"---the mutational event occurred or became "nodal" inside a phylogenetic branch.

[^8]: ^a^Summary of all RNM events detected in the phylogenetic analysis bearing functional potential (see Materials and Methods).

[^9]: ^b^Group of sequences with the same lineage nomenclature; "within"---the mutational event occurred or became "nodal" inside a phylogenetic branch.

[^10]: ^c^Mutation number 4 did not pass the SIFT score cutoff (see main text).
